China
China GPs commit $160m to local ADC player
DAC Biotech, a Chinese biotech company specializing in antibody-drug conjugates (ADCs) commonly used as targeted therapies for treating cancer, has raised RMB1 billion ($160 million) in Series C funding led by GL Ventures, CDG Capital, and CPE.
China self-driving truck start-up agrees $3.3b SPAC merger
Plus, a China-based autonomous driving technology developer that specializes in trucks, has agreed to merge with a special purpose acquisition company (SPAC) at a valuation of $3.3 billion.
China medical tech supplier AMS raises $100m
China and US-based Access Medical Systems (AMS) has raised a $100 million round co-led by Sequoia Capital China and GL Ventures.
Portfolio: CDH Investments & China Grand Pharma
The contribution CDH Investments has made to China Grand Pharma belies the size of its equity interest in the company. M&A, at home and overseas, has been central to the growth strategy
Source Code leads Series C for China online insurance broker
Yuanbao, a Chinese online insurance broker, has raised nearly RMB1 billion ($156 million) in Series C funding led by Source Code Capital. Other investors include Cathay Capital, Hike Capital, Northern Light Venture Capital, Qiming Venture Partners, and...
China’s Hope Medicine raises $56m Series B
Chinese innovative drug company Hope Medicine has raised a $56 million Series B round jointly led by Qiming Venture Partners and Grand Flight Investment.
China's ANE Logistics files for Hong Kong IPO
ANE Logistics, a Chinese road freight transportation business backed by Centurium Capital, CDH Investments, and CPE among others, has filed for a Hong Kong IPO.
PE-backed Waterdrop falls on debut after $360m US IPO
Waterdrop, a China-based insurance, medical crowdfunding and mutual aid platform, fell 19% on its New York Stock Exchange debut following a $360 million IPO.
5Y, Sequoia back China app-building platform
Huoban.com, a Chinese zero-code application building platform has raised $17 million in Series B funding led by 5Y Capital and Sequoia Capital China. Challenjers Capital also took part in the round.
DCP, Sequoia lead Series B for China's Valgen Medtech
DCP Capital has continued its run of investments in China’s medical devices industry by participating in a Series B funding round for Hangzhou Valgen Medtech.
CVC, CDPQ carve out China ad agency's global portfolio
CVC Capital Partners and Caisse de dépôt et placement du Québec (CDPQ) have agreed to acquire a majority stake in the international business of China-based advertising and marketing agency BlueFocus Group at a valuation of $350 million.
China audio platform Ximalaya files for US IPO
Ximalaya, China’s largest online audio platform, which counts the likes of Tencent Holdings, General Atlantic, and Goldman Sachs among its backers, has filed for a US IPO.
Ocean Link joins consortium pursuing 51job take-private
DCP Capital Partners has enlarged the consortium seeking to acquire Chinese online recruitment services platform 51job with the addition of Ocean Link Capital and the target company’s CEO.
GP profile: Samena Capital
Conservative yet contrarian, Samena Capital has carved its own path prioritizing patience, trust, and transparency. A younger generation of leadership is guiding entry into a new digital landscape
Asia technology: Anatomy of a rebound
Tech investment has been on a tear in Asia, with private equity joining venture capital at the party. While COVID-19 has contributed to these dynamics, the revival is rooted in deeper structural change
Chinese contact lens brand raises $65m
Dearer Medical, a Shanghai-based cosmetic contact lens manufacturer, has raised RMB420 million ($65 million) in Series B funding from CPE, Legend Capital, and Insight Capital.
Ince seeks $450 million for second China VC fund
Ince Capital is preparing to launch its second China venture capital fund with a target of $450 million, less than 18 months after closing its debut vehicle.
Buhuo Ventures completes renminbi fund restructuring
China’s Buhuo Ventures has closed its first US dollar-denominated fund at $100 million, following a GP-led cross-currency restructuring of a renminbi vehicle.
SIG leads $70m Series C for China's YiAuto
YiAuto, a Chinese new car marketplace, has raised a $70 million Series C round led by SIG. Existing investors GGV Capital, BlueRun Ventures, Sky9 Capital, and K2 Venture Partners also participated.
China AI chip designer Vastai raises $77m
Vastai Technologies, a China-based artificial intelligence (AI) chip designer, has raised RMB500 million ($77 million) in an extended Series A round led by Matrix Partners China and China Internet Investment Fund.
China's Mobvista acquires marketing business
Chinese digital marketing player Mobvista has acquired VC-backed local counterpart Reyun in a cash-and-stock transaction worth RMB1.5 billion ($232 million).
Trustar backs China beauty industry online services provider
Trustar Capital – formerly CITIC Capital Partners – has acquired a stake in Yifei Group, an online business service provider to China’s beauty and personal care industry, continuing its string of deals in this area over several years.